Effects of Denosumab Treatment and Discontinuation on Bone Mineral Density and Bone Turnover Markers in Postmenopausal Women with Low Bone Mass

Henry G. Bone; Michael A. Bolognese; Chui Kin Yuen; David L. Kendler; Paul D. Miller; Yu-Ching Yang; Luanda Grazette; Javier San Martin; J. Christopher Gallagher

首页> 外文期刊>The journal of clinical endocrinology and metabolism >Effects of Denosumab Treatment and Discontinuation on Bone Mineral Density and Bone Turnover Markers in Postmenopausal Women with Low Bone Mass

【24h】

Effects of Denosumab Treatment and Discontinuation on Bone Mineral Density and Bone Turnover Markers in Postmenopausal Women with Low Bone Mass

机译：地诺单抗治疗和停药对绝经后低骨量妇女骨密度和骨转换指标的影响

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Context:Denosumab treatment for 24 months increased bone mineral density (BMD) and reduced bone turnover markers (BTM) in postmenopausal women.

机译：背景：Denosumab治疗24个月，可使绝经后妇女的骨矿物质密度（BMD）升高，骨转换指标（BTM）降低。

著录项

来源
《The journal of clinical endocrinology and metabolism》 |2011年第4期|共9页
作者
Henry G. Bone; Michael A. Bolognese; Chui Kin Yuen; David L. Kendler; Paul D. Miller; Yu-Ching Yang; Luanda Grazette; Javier San Martin; J. Christopher Gallagher;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类代谢病;
关键词

相似文献

外文文献
中文文献
专利

1. Denosumab in treatment-naive and pre-treated with zoledronic acid postmenopausal women with low bone mass: Effect on bone mineral density and bone turnover markers [J] . Anastasilakis Athanasios D., Polyzos Stergios A., Efstathiadou Zoe A., Metabolism: Clinical and Experimental . 2015,第10期

机译：Denosumab在治疗中 - 幼稚和预处理的患有低骨质量的唑妥酸绝经妇女：对骨矿物质密度和骨质周转标记的影响
2. The three-year effect of a single zoledronate infusion on bone mineral density and bone turnover markers following denosumab discontinuation in women with postmenopausal osteoporosis [J] . Makras Polyzois, Papapoulos Socrates E., Polyzos Stergios A., Bone . 2020,第1期

机译：单一的唑酮酸盐对骨矿物质密度和骨质周转标志物的三年效应在绝经后骨质疏松症的妇女中停药后骨密度和骨质周转标记
3. Effect of denosumab on bone density and turnover in postmenopausal women with low bone mass after long-term continued, discontinued, and restarting of therapy: a randomized blinded phase 2 clinical trial. [J] . Amg-Bone-Loss-Study Group Bone . 2008,第2期

机译：地诺单抗对长期持续，中止和重新开始治疗的绝经后低骨量妇女的骨密度和周转率的影响：一项随机的2期盲临床试验。
4. Association of bone mineral density and mammographic breast density in premenopausal and postmenopausal Malaysian women: Study on women with and without breast cancer [C] . Norhayati Mohd Zain, Vengkatha Priya Seriramulu, Kanaga Kumari Chelliah, International Conference on Bio-engineering for Smart Technologies . 2016

机译：绝经前和绝经后马来西亚女性的骨矿物质密度与乳房X线照片乳房密度的关系：有无乳腺癌的女性研究
5. The relationship of vitamin D and selected nutrient intakes, sex hormone binding globulin and markers of bone turnover to bone mineral density in exercising and non-exercising postmenopausal women taking or not taking HRT. [D] . Sparks, Patricia Lynne. 2001

机译：在接受或不接受HRT的运动和非运动绝经后妇女中，维生素D与选定的营养摄入量，性激素结合球蛋白以及骨转换标志与骨矿物质密度的关系。
6. Effect of Denosumab on Bone Mineral Density and Markers of Bone Turnover among Postmenopausal Women with Osteoporosis [O] . A. Sánchez, L. R. Brun, H. Salerni, 2016

机译：地诺单抗对绝经后骨质疏松妇女骨矿物质密度和骨转换指标的影响
7. Effects of denosumab on bone mineral density and bone turnover in postmenopausal women transitioning from alendronate therapy [O] . David L Kendler, Christian Roux, Claude Laurent Benhamou, 2009

机译：Denosumab对蛋白妇女骨密度骨密度与骨质骨质骨质转换的影响

Effects of Denosumab Treatment and Discontinuation on Bone Mineral Density and Bone Turnover Markers in Postmenopausal Women with Low Bone Mass

摘要

著录项

相似文献

相关主题

期刊订阅